The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more clinical trials.
Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, ...
Discover how the XP3i enhances data logging with built-in functionality, greater capacity, and on-device analysis compared to the XP2i.
Acquisition is expected to strengthens Thermo Fisher’s position in delivering clinical information to pharma and biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback